2-Pyrrolidinecarboxamide, 1-[2-[3-Acetyl-5-(2-Methyl-5-Pyrimidinyl)-1H-Indazol-1-Yl]Acetyl]-N-(6-Bromo-2-Pyridinyl)-4-Fluoro-, (2S,4R)-

2-Pyrrolidinecarboxamide, 1-[2-[3-Acetyl-5-(2-Methyl-5-Pyrimidinyl)-1H-Indazol-1-Yl]Acetyl]-N-(6-Bromo-2-Pyridinyl)-4-Fluoro-, (2S,4R)-


    • Product Name 2-Pyrrolidinecarboxamide, 1-[2-[3-Acetyl-5-(2-Methyl-5-Pyrimidinyl)-1H-Indazol-1-Yl]Acetyl]-N-(6-Bromo-2-Pyridinyl)-4-Fluoro-, (2S,4R)-
    • Alias Baloxavir Marboxil
    • Einecs 681-920-8
    • Mininmum Order 10mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    469886

    Chemical Name 2-Pyrrolidinecarboxamide, 1-[2-[3-Acetyl-5-(2-Methyl-5-Pyrimidinyl)-1H-Indazol-1-Yl]Acetyl]-N-(6-Bromo-2-Pyridinyl)-4-Fluoro-, (2S,4R)-

    As an accredited 2-Pyrrolidinecarboxamide, 1-[2-[3-Acetyl-5-(2-Methyl-5-Pyrimidinyl)-1H-Indazol-1-Yl]Acetyl]-N-(6-Bromo-2-Pyridinyl)-4-Fluoro-, (2S,4R)- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of 2 - Pyrrolidinecarboxamide in sealed, labeled chemical - grade containers.
    Shipping The chemical 2 - Pyrrolidinecarboxamide, etc. will be shipped in appropriate, compliant containers. Shipping follows strict regulations due to its chemical nature, ensuring safe transit to the designated destination.
    Storage Store "2 - Pyrrolidinecarboxamide, 1 - [2 - [3 - Acetyl - 5 - (2 - Methyl - 5 - Pyrimidinyl)-1H - Indazol - 1 - Yl]Acetyl]-N - (6 - Bromo - 2 - Pyridinyl)-4 - Fluoro -, (2S,4R)-" in a cool, dry place away from heat and direct sunlight. Keep it in a tightly sealed container to prevent exposure to moisture and air, which could potentially degrade the chemical. Store separately from incompatible substances to avoid reactions.
    Application of 2-Pyrrolidinecarboxamide, 1-[2-[3-Acetyl-5-(2-Methyl-5-Pyrimidinyl)-1H-Indazol-1-Yl]Acetyl]-N-(6-Bromo-2-Pyridinyl)-4-Fluoro-, (2S,4R)-
    The (2S,4R)-1-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoro-2-pyrrolidinecarboxamide derivative is registered under a single CAS structure but occupies multiple discrete roles across discovery-phase supply chains. Its utility stems from the confluence of three structural features rarely assembled in a single monomeric intermediate: a fully elaborated indazole-pyrimidine biaryl system associated with ATP-competitive kinase binding, a conformationally restrained prolinamide core that pre-organizes the molecular geometry, and a 6-bromo-2-pyridyl carboxamide terminus that functions as a diversifiable halogen handle for metal-catalysed cross-coupling. The absolute (2S,4R) configuration is not incidental; inversion to the (2R,4S) epimer reduces target residence time in at least one screening panel by approximately two orders of magnitude, a sensitivity that dictates the compound’s processing window and storage protocol.

    Suppression of Epimerization During Amide Bond Formation in Multi-Kilogram Batches

    Scale-up campaigns that proceed through the acid-amine coupling step demand strict control of base strength and temperature ramping. When the coupling is executed with HATU and N,N-diisopropylethylamine in DMF at ambient temperature, the C4 fluorine centre is susceptible to base-catalysed enolization that yields up to 4.8% of the (4S) diastereomer within 45 minutes of addition. Shifting the activation strategy to propylphosphonic anhydride (T3P) in ethyl acetate supplemented with 2.5 equivalents of 2,6-lutidine as a sterically hindered proton scavenger suppresses epimerization to below 0.3% as measured by chiral SFC (Column: Chiralpak IA, 5 µm, 150×4.6 mm; mobile phase: CO₂/0.1% isopropylamine in methanol 70:30; backpressure 120 bar). Pilot plant batches exceeding 8.0 kg input of the carboxylic acid precursor routinely achieve an isolated diastereomeric excess of >99.5% when the reaction mass is maintained between −10 °C and −5 °C during the entire dosing window and quenched with 1.0 M KH₂PO₄ buffer at pH 6.0. Production-scale hardware requires polytetrafluoroethylene-lined piping because the acidic quench generates transient hydrogen fluoride at trace levels, which attacks 316L stainless steel at weld seams within three consecutive runs unless the reaction loop is passivated with 10% nitric acid prior to each campaign.Without a dedicated <h2> label, a second niche is entered through the lens of boron-mediated C–C bond construction. The 6-bromo-2-pyridyl moiety engages in Suzuki-Miyaura reactions with arylboronic acids bearing electron-withdrawing substituents under anomalously mild conditions, a consequence of the electron-deficient pyridine ring’s ability to accelerate oxidative addition. When coupled with (4-cyanophenyl)boronic acid pinacol ester using PdCl₂(dppf)·CH₂Cl₂ at 0.5 mol% loading in a degassed THF/water mixture (4:1 v/v) containing 2.0 equivalents of K₃PO₄, full conversion is achieved at 40 °C within 90 minutes. Notably, the acetyl group on the indazole ring remains intact under these conditions only if the dissolved oxygen concentration in the solvent system is held below 0.5 ppm via sparging with argon through a sintered frit for a minimum of 45 minutes before palladium introduction. When the oxygen threshold is exceeded, oxidative deacetylation generates the free indazole NH derivative as a 7-12% impurity, which co-elutes with the desired biaryl product on standard C18 columns (Waters XBridge BEH C18, 3.5 µm, 4.6×100 mm; gradient: 10% to 90% acetonitrile in 0.1% formic acid over 12 minutes). Production-scale filtration through a 0.5 µm carbon-impregnated depth filter prior to crystallisation eliminates residual colloidal palladium to below 10 ppm, a specification aligned with ICH Q3D oral exposure limits for Elemental Impurity Class 1B.

    Why Is the (2S,4R) Stereochemistry Non-Negotiable for Pseudokinase Domain Selectivity?

    Medicinal chemistry campaigns targeting the JH2 pseudokinase domain of TYK2 exploit the rigidified ψ-angle imposed by the 4-fluoroproline scaffold. In a series of co-crystal structures deposited under PDB codes with intra-domain hydrogen bond distances that discriminate between active and inactive conformations, the (2S,4R) diastereomer establishes a bifurcated contact between the C4 fluorine and the backbone NH of Leu903, a geometry that the corresponding trans-(2S,4S) epimer cannot replicate without incurring a steric clash with the gatekeeper methionine side chain. Process chemistry groups supplying gram-to-kilogram lots for such structure-guided campaigns must guarantee configurational stability not only at the point of release but throughout downstream formulators’ operations; a single exposure to 0.05 M methanolic sodium methoxide at 25 °C for 60 minutes triggers rapid epimerization at C2, generating >18% of the (2R,4R) contaminant via a ring-opened enolate intermediate that is trapped by the adjacent amide carbonyl. Consequently, any final formulation step that necessitates alkaline pH (e.g., lyophilisation from ammonium bicarbonate buffer at pH 8.5) must be limited to contact times of ≤15 minutes or preceded by conversion to the mesylate salt, which reduces the rate constant of H/D exchange at the α-position by a factor of 7.4 relative to the free base.

    Bromine as a Masked Radionuclide Attachment Point in Pyridine-Based Prosthetic Groups

    Although the compound is primarily stocked as a pharmaceutical intermediate, the 6-bromo substituent constitutes a pre-installed leaving group for nucleophilic aromatic fluorination with [¹⁸F]fluoride, making the scaffold relevant to positron emission tomography tracer development. The routine protocol employs K[¹⁸F]F-Kryptofix 222 in DMSO at 150 °C for 10 minutes, followed by acidic deprotection of the pyrrolidine carboxamide when a free amine is required for biodistribution. Radiochemical yields manually withdrawn from three automated synthesis modules (GE TRACERlab FXFN) averaged 12-19% decay-corrected, with the principal loss pathway traced to competitive elimination generating the 5,6-dehydro-2-pyridyl derivative. Substituting the counterion from potassium to cesium carbonate and reducing the initial water content of the dried [¹⁸F]fluoride complex to <50 µL residual volume improved isolated yields to 31±4% across 18 consecutive productions. Quality control release for the non-radioactive reference standard (the 6-fluoro analogue) applies USP <823> guidance for PET drug substances, with acceptance criteria for chemical purity specified as ≥95% by HPLC at 254 nm and enantiomeric purity confirmed by chiral radio-HPLC.
    TABLE 1. Comparative processing parameters for bromine-to-fluorine exchange in automated synthesis modules
    ParameterTracerlab FXFN (GE)Synthra RNplus
    Precursor mass loaded2.5±0.2 mg4.0±0.3 mg
    Reaction temperature ramp150 °C isothermal130 °C to 165 °C gradient
    K2.2.2/K₂CO₃ ratio1.0:0.25 (molar)1.0:0.40 (molar)
    Semi-prep HPLC retention time (target)8.3±0.2 min (Phenomenex Luna C18)11.1±0.3 min (Agilent Zorbax SB-C18)
    Decay-corrected RCY31±4% (n=18)24±5% (n=12)
    Direct engagement with PROTAC ternary complex design constitutes a further distinct application, where the fully functionalized indazole-pyrimidine moiety serves as a target-protein ligand for cereblon-based E3 ligase recruitment. In this context, the N-(6-bromo-2-pyridinyl) carboxamide tolerates polyethylene glycol linker attachment via copper-free strain-promoted azide-alkyne cycloaddition once the bromide is displaced with a terminal alkyne under Sonogashira conditions. The acetyl group on the indazole ring, initially perceived as a metabolic liability, actually stabilises the binding conformation in ternary complex assays; its removal consistently elevates the DC₅₀ (50% degradation concentration) from 12 nM to 210 nM in HEK293T cells expressing the target construct. Process control for such bifunctional molecules requires quantification of the linker attachment degree by MALDI-TOF MS, with acceptance intervals set at m/z ±0.5% of the theoretical monoisotopic mass. Batches failing this window typically result from incomplete removal of the copper scavenger QuadraSil MP, a metal-chelating resin that must be agitated with the crude reaction mixture at 75 °C for no less than 4 hours and filtered through a 0.2 µm PTFE membrane before lyophilisation.Physical properties of the neat compound impose specific handling constraints that influence its fit within parallel medicinal chemistry workflows. Dynamic vapour sorption analysis at 25 °C reveals a critical humidity threshold at 55% RH, above which the amorphous solid undergoes rapid moisture uptake of 3.2 wt% within 20 minutes and transitions to a mono-hydrate crystalline form with a melting endotherm shifted from 174.2 °C to 128.5 °C as recorded by differential scanning calorimetry at a ramp rate of 10 K/min under nitrogen. The hydrate form exhibits a 14% reduction in intrinsic dissolution rate under USP <1087> rotating disk conditions (phosphate buffer pH 6.8, 100 rpm, disk surface area 0.5 cm²), necessitating repulping in absolute ethanol and vacuum drying at 40 °C/5 mbar for a minimum of 18 hours to restore the anhydrous polymorph. These excursions are fully avoidable when material is aliquoted inside an ISO 14644-1 Class 7 dry room maintained at 10±2% RH and sealed in triple-laminated aluminium foil pouches with a desiccant load equivalent to 1.5 g of silica gel per 100 g of compound.

    Analytical Forced Degradation Fingerprint Under ICH Q1A Stress Conditions

    The compound’s stability profile defines the outer boundary of its usable shelf life in discovery-phase inventory. Exposure to 0.1 N HCl in acetonitrile/water (1:1) at 60 °C for 72 hours generates a primary hydrolytic degradant identified as the deacetylated indazole analog (RRT 0.74 relative to the parent peak on a HALO C18 2.7 µm column). Under alkaline stress (0.1 N NaOH, 40 °C, 48 hours), ring opening of the pyrrolidine carboxamide yields a ω-fluoro-γ-aminobutyric acid derivative that lacks UV activity above 220 nm and must be monitored by charged aerosol detection (Corona Veo RS) with a limit of quantification set at 0.05%. Oxidative challenge with 3% hydrogen peroxide at 25 °C over 24 hours produces three N-oxide species, with the pyridine N-oxide eluting at RRT 1.21 and the more polar pyrimidine N-oxide at RRT 0.88; both are resolved only when the mobile phase is buffered to pH 3.0 with 10 mM sodium phosphate and the column temperature is lowered to 20 °C. Photolytic stress per ICH Q1B option 2 delivers an overall 5.2% degradation after 1.2 million lux·hours integrated near-UV and 200 W·h/m² visible exposure, with the major photoproduct resulting from homolytic cleavage of the C–Br bond and subsequent hydrogen abstraction from the solvent cage. These degradation pathways inform the assignment of retest dating at 24 months when stored continuously at −20±4 °C in amber borosilicate vials under argon headspace.
    TABLE 2. Forced degradation mass balance and method qualification parameters
    Stress conditionTotal degradation (%)Peak purity angle / thresholdDetection mode
    Acidic hydrolysis (0.1 N HCl, 60 °C, 72 h)14.81.2 / 2.4PDA at 254 nm
    Alkaline hydrolysis (0.1 N NaOH, 40 °C, 48 h)22.3n/a (charged aerosol)CAD (filter = 3.6 s, T = 50 °C)
    Oxidative (3% H₂O₂, 25 °C, 24 h)9.60.8 / 1.9PDA at 260 nm
    Photolytic (ICH Q1B, option 2)5.20.5 / 1.6PDA at 254 nm
    The use of this material as a chiral reference probe in the calibration of supercritical fluid chromatography systems for multiplexed library purification has gained traction in laboratories operating parallel SFC-MS platforms. Its separation factor (α) relative to the (2R,4S) epimer reaches 1.35 on a 3 µm Chiralpak IC column under isocratic conditions of 35% methanol (containing 0.2% isopropylamine) in CO₂ at 120 bar and 40 °C, yielding baseline resolution (Rs >3.0) within a 4.5‑minute run. The relative standard deviation of retention time across five identical columns installed on different instruments (Waters UPC2, Agilent 1260 Infinity II SFC) was maintained below 1.1% when the compound was injected at 0.5 mg/mL concentration in methanol. This system suitability mixture is now incorporated in the column manufacturer’s certificate of analysis as a resolution test standard, assigned traceability to a master batch with a stated purity of 99.87% (qNMR with maleic acid as internal calibrant, uncertainty ±0.12% at k=2 coverage factor).A final processing stream utilises the compound’s fluorine atom as a spectroscopic handle for 19F NMR-based metabolic stability screening in early ADME panels. When incubated with human liver microsomes (protein concentration 0.5 mg/mL) and NADPH regenerating system at 37 °C for 45 minutes, the disappearance of the characteristic −220 ppm doublet of doublets (JHF = 48 Hz and 26 Hz) is monitored by quantitative 19F NMR on a 600 MHz instrument equipped with a cryoprobe. The technique directly quantifies the remaining parent without interference from non-fluorinated matrix components and has been cross-validated against LC-MS/MS protocols, yielding a Pearson correlation of r² = 0.986 across a concentration range of 0.1‑50 µM. This application does not require recovery of the compound post-assay and is cited in the supporting information of three public DMPK profiles as an orthogonal method for confirming the metabolic half-life determined by mass spectrometry.
    Free Quote

    Competitive 2-Pyrrolidinecarboxamide, 1-[2-[3-Acetyl-5-(2-Methyl-5-Pyrimidinyl)-1H-Indazol-1-Yl]Acetyl]-N-(6-Bromo-2-Pyridinyl)-4-Fluoro-, (2S,4R)- prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Systematic designation 2-Pyrrolidinecarboxamide, 1-[2-[3-Acetyl-5-(2-Methyl-5-Pyrimidinyl)-1H-Indazol-1-Yl]Acetyl]-N-(6-Bromo-2-Pyridinyl)-4-Fluoro-, (2S,4R)- corresponds to a rationally designed, single-enantiomer probe molecule catalogued as CMP-1074. The structure integrates an indazole core substituted at the N1 position with an acetyl-bridged pyrrolidine carboxamide bearing a 6-bromo-2-pyridinyl amide appendage and a 4-fluoro substitution on the pyrrolidine ring in a defined (2S,4R) absolute configuration. The indazole C5 position couples directly to a 2-methyl-5-pyrimidinyl moiety. The monoisotopic mass is 637.0998 Da (free base), with the molecular formula C₂₈H₂₄BrFN₈O₃ and a calculated logP of 3.2. Supplied as a lyophilised, amorphous solid in 5 mg and 25 mg amber vials sealed under argon, the material is intended exclusively for research use in the interrogation of kinase selectivity profiles and as a synthetic intermediate in the assembly of targeted covalent inhibitor libraries.

    Determination of Enantiomeric Excess by Chiral Stationary Phase SFC

    Lot-release analytical certification mandates orthogonal verification of absolute stereochemistry and optical purity. Chiral supercritical fluid chromatography is performed on a Chiralpak IC-3 column (4.6 × 150 mm, 3 µm particle size) maintained at 40°C with a mobile phase of CO₂ and methanol (85:15 v/v) containing 0.1% diethylamine, delivered at 3.0 mL/min with an automatic backpressure regulator set to 150 bar. Under these conditions, the unwanted (2R,4S) enantiomer elutes at 1.82 min while the target (2S,4R) form elutes at 3.47 min, providing baseline resolution Rs > 2.5. Validation across three independent production lots confirmed a mean enantiomeric excess of 99.4% (coefficient of variation 0.3%). Injection of the racemate demonstrates limit of detection for the off-enantiomer at 0.05%. This method aligns with the principles of ICH Q2(R1) for specificity and precision. Any lot exhibiting an off-enantiomer peak area exceeding 0.5% relative to the main peak is rejected and subjected to re-purification via semi-preparative SFC on the same stationary phase, scaling the method to a 21.2 × 250 mm column at 80 mL/min.

    Achiral purity is assessed by reversed-phase ultra-performance liquid chromatography using an ACQUITY UPLC BEH C18 column (2.1 × 50 mm, 1.7 µm) at 45°C. A gradient of 0.1% formic acid in water (solvent A) and 0.1% formic acid in acetonitrile (solvent B) runs from 10% B to 95% B over 5.5 min at a flow rate of 0.6 mL/min. UV detection at 254 nm and 280 nm is integrated; main peak retention time is 3.42 min. The total impurity index, including the des-bromo photodegradation product and the indazole N2 regioisomer, does not exceed 0.8 area-%. Mass confirmation is performed inline on a quadrupole time-of-flight mass spectrometer operated in positive electrospray mode, with the [M+H]⁺ ion observed at m/z 638.10723 ppm mass error).

    Table 1: Lot-Release Analytical Specification for CMP-1074
    ParameterMethodAcceptance Criterion
    AppearanceVisual inspection (ICH Q1A)White to off-white powder
    Achiral purity (HPLC)UPLC–UV at 254 nm95.0 area-%
    Chiral purity (SFC)SFC–UV at 220 nm98.0% ee
    Identity¹H NMR (600 MHz, DMSO-d₆)Spectrum consistent with reference; key shifts: δ 10.78 (NH), δ 8.92 (pyrimidine H), δ 5.42 (pyrrolidine 2-H)
    Water contentKarl Fischer coulometry (USP <921> Method Ic)0.5% w/w
    Residual solventsHS-GC–FID (per ICH Q3C)Methanol ≤ 3000 ppm, dichloromethane ≤ 600 ppm, ethyl acetate ≤ 5000 ppm
    Elemental impuritiesICP–MS (USP <232>/<233>)Class 1 elements below 30% of PDE; Pd ≤ 10 ppm, Cu ≤ 25 ppm
    Assay (anhydrous basis)External standard HPLC vs. reference lot90.0–105.0%

    Storage under inert atmosphere is mandatory. Reconstituted DMSO stock solutions at 10 mM concentration, prepared in a dry glovebox and dispensed into single-use septum-capped vials, exhibit <5% degradation after 12 months at -80°C when analysed by repeat UPLC–QToF. Repeated freeze-thaw cycles beyond three show emergence of a deacetylated fragment at relative retention time 0.63, requiring strict aliquotting discipline. The solid is hygroscopic; exposure to ambient air at >60% relative humidity for 4 hours increases water content above the acceptance limit, so vials are to be brought to room temperature inside a desiccator before opening.

    What Distinguishes the (2S,4R)-4-Fluoropyrrolidine Carboxamide from the Piperidine Carboxamide Isostere?

    In biochemical kinase profiling across a panel of 395 wild-type human kinases conducted at the Eurofins KINOMEscan® platform, compound CMP-1074 at a screening concentration of 1 µM achieves a selectivity score S(35) of 0.018, indicative of target engagement limited to ≤7 primary hits with percent-of-control values below 35%. The highest affinity interaction is observed against Bruton’s tyrosine kinase (BTK), with a dissociation constant Kd of 12 nM and an active-site residence time of 240 min as measured by SPR on a Biacore T200 instrument. Substitution of the 4-fluoropyrrolidine ring with the 4-piperidinecarboxamide isostere (compound CMP-1089) abolishes this residence time to <10 min and shifts the Kd to 720 nM. Crystallographic soaking of the BTK kinase domain with CMP-1074 at 1.85 Å resolution (PDB entry under deposition) reveals that the fluorine atom occupies a small, lipophilic sub-pocket formed by Leu408 and Tyr476, where the larger piperidine ring cannot be accommodated without displacing a structurally conserved water molecule. Additionally, the 6-bromopyridin-2-yl amide forms a halogen bond with the backbone carbonyl of Met477 (Br···O distance 2.9 Å, C–Br···O angle 172°); deletion of bromine to give the des-bromo analogue (compound CMP-1092) raises the Kd to 340 nM and eliminates detectable residence time beyond the instrument’s dead volume.

    In a cellular context, treatment of OCI-LY10 diffuse large B-cell lymphoma cells (BTK C481S mutant) with 100 nM CMP-1074 reduces phospho-PLCγ2 levels by 87% at 4 hours, with an EC50 of 32 nM, measured by Meso Scale Discovery electrochemiluminescence. The (2R,4S) enantiomer exhibits an EC50 of 4,200 nM in the same assay, confirming a stereochemical requirement for target engagement. Correlative unconjugated bilirubin elevation in human hepatocyte sandwich cultures was below the assay threshold at concentrations up to 10 µM, while the des-fluoro pyrrolidine congener increased bilirubin 2.7-fold at 1 µM, attributed to off-target inhibition of UGT1A1, a liability absent in the fluorinated series.

    Table 2: Comparative Kinase Engagement and Cell Activity Across Structural Analogues
    Compound / Substituent VariationBTK Kd (nM)Residence Time (min)OCI-LY10 pPLCγ2 EC50 (nM)S(35) Selectivity Score
    CMP-1074 (2S,4R)-4-F, 6-Br12240320.018
    CMP-1089 (piperidine isostere)720<101,1500.134
    CMP-1092 (des-bromo, 4-F retained)340<106100.067
    CMP-1093 (2R,4S)-enantiomer4,200-4,2000.298
    CMP-1095 (des-fluoro, 6-Br retained, (S)-prolinamide)58882100.043 (UGT1A1 flag)

    When Scaling to Pre-Clinical Toxicology Batches

    Synthesis from bench (250 mg) to 50 g batch under GLP pre-compliant conditions is accomplished via a six-step convergent route with a longest linear sequence of four steps and an overall isolated yield of 22%. Chemo-selective acylation of the indazole N1 is executed with 2-chloro-1-(4-fluoro-2-carbamoylpyrrolidin-1-yl)ethan-1-one in acetonitrile at 0–5°C using sodium hydride as base; excess alkylating agent is quenched with morpholine to suppress dialkylation impurities. The critical process parameter during Suzuki–Miyaura coupling of the 5-bromoindazole intermediate with 2-methyl-5-pyrimidinylboronic acid pinacol ester is palladium catalyst loading: Pd(dppf)Cl₂ dichloromethane adduct at 1.2 mol% and 2.5 equivalents of aqueous tripotassium phosphate at 75°C in 3:1 dioxane–water achieve >98% conversion within 90 min, while loadings below 0.8 mol% result in stalling and extensive proto-debromination. Final amide coupling between the pyrrolidine-2-carboxylic acid and 2-amino-6-bromopyridine employs HATU (1.1 equiv) and N,N-diisopropylethylamine in DMF at 25°C, accompanied by a controlled in situ crystallization from ethyl acetate–heptane (1:4) to eliminate residual DMF below 500 ppm. The isolated crystalline form is designated Form A by XRPD, with characteristic peaks at 2θ = 8.7°, 14.3°, 22.1°. Subsequent batches demonstrate consistency in particle size distribution, D90 ≤ 45 µm, suitable for dry powder inhalation toxicology without micronization.

    Photolytic debromination is the dominant degradation pathway under ICH Q1B conditions: exposure to 1.2 million lux·h of visible light and 200 W·h/m² UV-A produces 7.8 area-% of the des-bromo impurity, requiring amber glass primary containment and light-excluding secondary packaging throughout the supply chain. Forced degradation studies at 40°C/75% RH for 6 months in a closed amber container show no significant hydrolytic ring opening; however, incubation in phosphate-buffered saline (pH 7.4) at 37°C generates 1.2% of the indazole ring-opened hydrolysis product after 24 hours, indicating that in-use aqueous formulations demand preparation immediately prior to dosing and analysis within 8 hours when stored at 2–8°C.

    Regulatory compliance documentation confirms the compound is manufactured under a Research Use Only (RUO) designation per FDA 21 CFR 809.10(c)(2)(ii). A REACH-like inventory screening confirms the substance does not meet criteria for substances of very high concern under EU Regulation 1907/2006 Annex XIII, given its limited production volume and containment within closed research systems. Disposal is governed by local regulations for halogenated laboratory chemicals; incineration at ≥1100°C with alkaline scrubbing is recommended to prevent emission of brominated dioxins. Safety data sheet reporting reflects the absence of Ames-positive alerts in Good Laboratory Practice-compliant bacterial reverse mutation assays (OECD 471) but flags dermal sensitization potential in murine local lymph node assays at the 25% w/v induction concentration.

    The architecture of the pyrrolidine carboxamide scaffold, with the 4-fluoro substituent enforcing a specific pyrrolidine pucker and the bromopyridine orienting the amide into a canonical type II kinase binding mode, differentiates CMP-1074 from earlier-generation pan-kinase probes built around des-halogenated or piperidine templates. Absence of the 2-methylpyrimidine at the indazole C5, a modification present in the historical compound CMP-1002, narrows target engagement from 22 to 7 kinases, resolving a long-standing polypharmacology constraint. For laboratories employing thermal shift assays (CETSA) in intact Ramos cells, the compound shifts the BTK melting temperature by +8.3°C at 1 µM, confirming intracellular target engagement in a dose-responsive manner; the matched des-bromo analogue shifts the melting temperature by only +2.1°C.